First-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor
Buyer: Bicony Therapeutics GmbH
- Published
- 10 May 2024
- Place of performance
- DED51
- Procedure
- Negotiated procedure
- Lots
- 1
- Documents
- 1
- Notice number
- 00274800-2024
- Reference
- b7bb24ef-ab18-49d3-b7dd-725d0c1c5a6e
- Official source
- Official source
CPV codes
- 85145000Servicios prestados por laboratorios médicos
- 85148000Servicios de análisis médicos
Description
The contract to be awarded is for a CRO to conduct a multicenter, first-in-human Phase I dose-escalation study of an antibody-based immunotherapy in patients with solid tumors
Official publications
- TED · 00274800-2024 · 10 May 2024
- OJS · 91/2024 · 10 May 2024
Other tenders from Bicony Therapeutics GmbH
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is Bicony Therapeutics GmbH (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.